← Back to Clinical Trials
Recruiting NCT07201480

NCT07201480 Death Anxiety, Depression and Anxiety: An Experimental Study

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT07201480
Status Recruiting
Phase
Sponsor Babes-Bolyai University
Condition Death Anxiety
Study Type INTERVENTIONAL
Enrollment 128 participants
Start Date 2025-03-01
Primary Completion 2025-12-30

Eligibility & Interventions

Sex All sexes
Min Age 18 Years
Max Age 65 Years
Study Type INTERVENTIONAL
Interventions
Mortality Salience PromptsDental Pain Prompts

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 128 participants in total. It began in 2025-03-01 with a primary completion date of 2025-12-30.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

The goal of this experimental study is to investigate the transdiagnostic role of death anxiety in depression and anxiety symptoms in participants from the general population. The main questions it aims to answer are: 1. Does the mortality salience task induce death anxiety? 2. Does the experimental group present an increase in depression and anxiety symptoms following the mortality salience task? The investigators will compare the experimental condition to a control condition to see if the death anxiety induction is responsible for the expected increase in depression and anxiety symptoms. The mortality salience prompt will be asking participants to elaborate on their thoughts and feelings surrounding death and dying, including what they think happens during death. The dental pain prompt will ask participants to do the same, only in regards to the thought of having dental pain. Experimental group: participants will undergo a pen-and-paper writing task where they will be asked to answer two questions: 1. "Please briefly describe the emotions that the thought of your own death arouses in you." 2. "Jot down, as specifically as you can, what you think will happen to you physically as you die and once you are physically dead." Control group: 1. "Please briefly describe the emotions that the thought of dental pain arouses in you." 2. "Jot down, as specifically as you can, what you think happens to you physically as you experience dental pain and once you have physically experienced dental pain."

Eligibility Criteria

Inclusion Criteria: * Age over 18 years. * Living in Cluj-Napoca (or otherwise willing and able to participate in the lab task) Exclusion Criteria: * Personality disorder diagnosis * Psychotic disorder diagnosis * Suicidal ideation

Contact & Investigator

Central Contact

Roxana Cardoș, PhD

✉ roxanaoltean@psychology.ro

📞 0040751477323

Frequently Asked Questions

Who can join the NCT07201480 clinical trial?

This trial is open to participants of all sexes, aged 18 Years or older, up to 65 Years, studying Death Anxiety. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT07201480 currently recruiting?

Yes, NCT07201480 is actively recruiting participants. Contact the research team at roxanaoltean@psychology.ro for enrollment information.

Where is the NCT07201480 trial being conducted?

This trial is being conducted at Cluj-Napoca, Romania.

Who is sponsoring the NCT07201480 clinical trial?

NCT07201480 is sponsored by Babes-Bolyai University. The trial plans to enroll 128 participants.

Related Trials

Related Intelligence Guides

In-depth guides covering this condition's trials, eligibility, and what to expect.

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: July 2026  ·  Data Methodology